Search results for "Geriatrics"

showing 10 items of 1388 documents

Differences on autobiographical memory in healthy aging and Alzheimer’s disease

2020

EpidemiologyAutobiographical memoryHealth PolicyNeuropsychologyEarly detectionDiseasePsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceNeurology (clinical)Geriatrics and GerontologyCognitive declineHealthy agingPsychologyClinical psychologyAlzheimer's & Dementia
researchProduct

P2‐511: From in silico to in vitro to in vivo: ‐ Novel approach in Alzheimer's disease drug discovery

2011

EpidemiologyDrug discoverybusiness.industryHealth PolicyIn silicoDiseaseComputational biologyIn vitroPsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceIn vivoMedicineNeurology (clinical)Geriatrics and GerontologybusinessAlzheimer's & Dementia
researchProduct

P4‐244: Progranulin (GRN), a protein mutated in frontotemporal dementia with ubiquitin‐positive inclusions (FTLD‐U), is abundantly expressed in human…

2009

EpidemiologyHealth PolicyA proteinBiologymedicine.diseaseUbiquitin-positive inclusionsPsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceCancer researchmedicineNeurology (clinical)Geriatrics and GerontologyFrontotemporal dementiaAlzheimer's & Dementia
researchProduct

P3‐183: Role of RCAN1, a gene involved in the adaptation to oxidative stress, in Alzheimer's pathology

2011

EpidemiologyHealth PolicyBiologymedicine.disease_causePsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeurosciencemedicineNeurology (clinical)Geriatrics and GerontologyAdaptationGeneNeuroscienceOxidative stressAlzheimer's & Dementia
researchProduct

O3‐10‐05: ROBUST MOLECULAR PROPERTIES UNDERLYING REGIONAL VULNERABILITY TO AMYLOID DEPOSITION AND NEURODEGENERATION IN ALZHEIMER'S DISEASE

2018

EpidemiologyHealth PolicyNeurodegenerationVulnerabilityDiseaseBiologymedicine.diseasePsychiatry and Mental healthCellular and Molecular NeuroscienceAmyloid depositionDevelopmental NeurosciencemedicineNeurology (clinical)Geriatrics and GerontologyNeuroscienceAlzheimer's & Dementia
researchProduct

IC‐P‐024: Localization of hippocampal atrophy in Alzheimer's disease

2011

The hippocampus presents the highest rate of atrophy in the early stage of Alzheimer's disease (AD), with more pronounced neuron loss reported in CA1 and subiculum. The aim of this study is to increase the discrimination power of hippocampal shape analysis between AD and normal controls (NC) by focusing on the subregions with atrophy associated with AD and describing the localized shape changes using statistical shape models (SSMs).

EpidemiologyHealth PolicySubiculumDiseaseBiologyHippocampal formationmedicine.diseaseHippocampal atrophyNeuron lossPsychiatry and Mental healthCellular and Molecular NeuroscienceAtrophynervous systemDevelopmental NeurosciencemedicineNeurology (clinical)Geriatrics and GerontologyNeuroscienceShape analysis (digital geometry)Alzheimer's & Dementia
researchProduct

P4‐117: Low mood in late life and risk of amnestic versus other cognitive impairment with and without dementia: A longitudinal community‐based study

2008

EpidemiologyHealth Policymedicine.diseaseCommunity based studyPsychiatry and Mental healthCellular and Molecular NeuroscienceMoodDevelopmental NeurosciencemedicineDementiaNeurology (clinical)Geriatrics and GerontologyCognitive impairmentPsychologyClinical psychologyCognitive psychologyAlzheimer's & Dementia
researchProduct

IC‐P‐122: Association of hippocampus head diffusivity and episodic memory performance in early Alzheimer's disease

2009

Epidemiologybusiness.industryHead (linguistics)Long-term memoryHealth PolicyHippocampusDiseasePsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceMedicineNeurology (clinical)Geriatrics and GerontologyAssociation (psychology)businessEpisodic memoryNeuroscienceAlzheimer's & Dementia
researchProduct

P3–247: Functional consequences of LRP expression on familiar Alzheimer disease APP mutations

2006

Epidemiologybusiness.industryHealth PolicyBioinformaticsmedicine.diseasePsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceExpression (architecture)medicineNeurology (clinical)Geriatrics and GerontologyAlzheimer's diseasebusinessAlzheimer's & Dementia
researchProduct

P2–182: Anxiety and depressive symptoms as predictors of progression from mild cognitive impairment to Alzheimer's disease

2006

Epidemiologybusiness.industryHealth PolicyDiseasePsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceMedicineAnxietyNeurology (clinical)Geriatrics and Gerontologymedicine.symptombusinessCognitive impairmentDepressive symptomsClinical psychologyAlzheimer's & Dementia
researchProduct